Literature DB >> 12475186

Retinoic acid modulates gap junctional intercellular communication in hepatocytes and hepatoma cells.

C Ara1, M Massimi, L Devirgiliis Conti.   

Abstract

Gap junctional communication permits the direct exchange of small molecules and ions and has been implicated in tissue homeostasis/metabolite exchange. The lack of gap junctional intercellular communication (GJIC) plays important roles in the promotion and progression of carcinogenesis. In the present study, we demonstrate that treatment of human hepatoma Hep G2 cells with retinoic acid (RA) results in increased amounts and phosphorylation of connexins, their stabilisation in plasma membrane plaques and enhanced GJIC. In cultured fetal hepatocytes, which represent a non-transformed, proliferating and incompletely differentiated liver system, the effects of RA are limited to the establishment of connexin in areas of cell-cell contact and the improvement of GJIC. This suggests that modulation of cell-cell channel communication by RA occurs differently in these two experimental models: while RA is able to revert cell transformation in Hep G2 cells, in fetal hepatocytes it may induce the expression of a more differentiated phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475186     DOI: 10.1007/pl00012503

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  10 in total

1.  Aberrant distribution of junctional complex components in retinoic acid receptor alpha-deficient mice.

Authors:  Sanny S W Chung; Cindy Choi; Xiangyuan Wang; Loretta Hallock; Debra J Wolgemuth
Journal:  Microsc Res Tech       Date:  2010-06       Impact factor: 2.769

2.  HuR regulates gap junctional intercellular communication by controlling beta-catenin levels and adherens junction integrity.

Authors:  Niloofar Ale-Agha; Stefanie Galban; Christiane Sobieroy; Kotb Abdelmohsen; Myriam Gorospe; Helmut Sies; Lars-Oliver Klotz
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

3.  Electrical excitability of early neurons in the human cerebral cortex during the second trimester of gestation.

Authors:  Anna R Moore; Radmila Filipovic; Zhicheng Mo; Matthew N Rasband; Nada Zecevic; Srdjan D Antic
Journal:  Cereb Cortex       Date:  2008-11-17       Impact factor: 5.357

4.  Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.

Authors:  Zu-Sen Wang; Li-Qun Wu; Xin Yi; Chao Geng; Yu-Jun Li; Ru-Yong Yao
Journal:  BMC Cancer       Date:  2013-06-24       Impact factor: 4.430

5.  Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation.

Authors:  M Ionta; M C Rosa; R B Almeida; V M Freitas; P Rezende-Teixeira; G M Machado-Santelli
Journal:  Braz J Med Biol Res       Date:  2012-05-24       Impact factor: 2.590

6.  Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition.

Authors:  Yan Yang; Shu-Kui Qin; Qiong Wu; Zi-Shu Wang; Rong-Sheng Zheng; Xu-Hui Tong; Hao Liu; Liang Tao; Xian-Di He
Journal:  Oncol Rep       Date:  2013-12-05       Impact factor: 3.906

Review 7.  The role of gap junctions in inflammatory and neoplastic disorders (Review).

Authors:  Pui Wong; Victoria Laxton; Saurabh Srivastava; Yin Wah Fiona Chan; Gary Tse
Journal:  Int J Mol Med       Date:  2017-01-17       Impact factor: 4.101

Review 8.  Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma.

Authors:  Mara Massimi; Federica Ragusa; Silvia Cardarelli; Mauro Giorgi
Journal:  Cells       Date:  2019-11-25       Impact factor: 6.600

9.  All-trans retinoic acid restores gap junctional intercellular communication between oral cancer cells with upregulation of Cx32 and Cx43 expressions in vitro.

Authors:  Juan Wang; Yaohui Dai; Yulei Huang; Xiaohua Chen; Hong Wang; Yun Hong; Juan Xia; Bin Cheng
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-07-01

10.  Visual impairment reversal with oral acitretin therapy in keratitis-ichthyosis-deafness (KID) syndrome.

Authors:  Christopher M Wolfe; Alexander Davis; Tarek S Shaath; George F Cohen
Journal:  JAAD Case Rep       Date:  2017-11-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.